Search results
Results from the WOW.Com Content Network
On Thursday, Regeneron Pharmaceuticals Inc (NASDAQ:REGN) reported third-quarter adjusted EPS of $12.46, up 8% year-over-year, beating the consensus of $11.69. The company reported sales of $3.72 ...
Would a stock split help lead Regeneron Pharmaceuticals shares higher?
Regeneron (REGN) closed at $615.88 in the latest trading session, marking a -0.8% move from the prior day. Skip to main content. 24/7 Help. For premium support please call: 800-290-4726 ...
Shares of Regeneron were down over 2% in premarket trading. Eylea, jointly developed with Bayer AG, has driven Regeneron's earnings for years, but sales have now come under pressure, partly from ...
For premium support please call: 800-290-4726 more ways to reach us
Video. Follow Us. Regeneron stock surges on positive results in eye disease drug trial. September 8, 2022 at 12:57 PM ...
On Friday, Regeneron Pharmaceuticals Inc (NASDAQ:REGN) announced that the European Medicines Agency's Committee for Medicinal Products for Human Use has adopted a positive opinion recommending ...
Top Stock Reports for Oracle, Intuit & Regeneron Pharmaceuticals